Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 79

1.

Clinical relevance of acute cerebral microinfarcts in vascular cognitive impairment.

Ferro DA, van den Brink H, Exalto LG, Boomsma JMF, Barkhof F, Prins ND, van der Flier WM, Biessels GJ; TRACE-VCI study group.

Neurology. 2019 Apr 2;92(14):e1558-e1566. doi: 10.1212/WNL.0000000000007250. Epub 2019 Mar 8.

PMID:
30850444
2.

Cortical Microinfarcts on 3T Magnetic Resonance Imaging in Cerebral Amyloid Angiopathy.

van den Brink H, Zwiers A, Switzer AR, Charlton A, McCreary CR, Goodyear BG, Frayne R, Biessels GJ, Smith EE.

Stroke. 2018 Aug;49(8):1899-1905. doi: 10.1161/STROKEAHA.118.020810.

PMID:
29986931
3.

[3D printed medical devices and anatomical models: What kind of distribution and which uses in French hospitals?]

Pierreville J, Serrano C, van den Brink H, Prognon P, Pineau J, Martelli N.

Ann Pharm Fr. 2018 Mar;76(2):139-146. doi: 10.1016/j.pharma.2017.12.001. Epub 2017 Dec 23. French.

PMID:
29277367
4.

Existing reporting guidelines for clinical trials are not completely relevant for implantable medical devices: a systematic review.

Motte AF, Diallo S, van den Brink H, Châteauvieux C, Serrano C, Naud C, Steelandt J, Alsac JM, Aubry P, Cour F, Pellerin O, Pineau J, Prognon P, Borget I, Bonan B, Martelli N.

J Clin Epidemiol. 2017 Nov;91:111-120. doi: 10.1016/j.jclinepi.2017.07.005. Epub 2017 Jul 18. Review.

PMID:
28728922
5.

How physical therapists instruct patients with stroke: an observational study on attentional focus during gait rehabilitation after stroke.

Kal E, van den Brink H, Houdijk H, van der Kamp J, Goossens PH, van Bennekom C, Scherder E.

Disabil Rehabil. 2018 May;40(10):1154-1165. doi: 10.1080/09638288.2017.1290697. Epub 2017 Feb 24.

PMID:
28637152
6.

HARMONIZING HEALTH TECHNOLOGY ASSESSMENT PRACTICES IN UNIVERSITY HOSPITALS: TO WHAT EXTENT IS THE MINI-HTA MODEL SUITABLE IN THE FRENCH CONTEXT?

Martelli N, Devaux C, van den Brink H, Billaux M, Pineau J, Prognon P, Borget I.

Int J Technol Assess Health Care. 2017 Jan;33(2):307-314. doi: 10.1017/S0266462317000393. Epub 2017 Jun 5.

PMID:
28580892
7.

[Mindfulness training for psychiatrists in residency: a pilot study].

Hoenders HJ, Booij SH, Knegtering H, van den Brink H.

Tijdschr Psychiatr. 2016;58(11):809-813. Dutch.

8.

Advantages and disadvantages of 3-dimensional printing in surgery: A systematic review.

Martelli N, Serrano C, van den Brink H, Pineau J, Prognon P, Borget I, El Batti S.

Surgery. 2016 Jun;159(6):1485-1500. doi: 10.1016/j.surg.2015.12.017. Epub 2016 Jan 30. Review.

PMID:
26832986
9.

New French Coverage with Evidence Development for Innovative Medical Devices: Improvements and Unresolved Issues.

Martelli N, van den Brink H, Borget I.

Value Health. 2016 Jan;19(1):17-9. doi: 10.1016/j.jval.2015.10.006. Epub 2015 Nov 21.

10.

Combining multi-criteria decision analysis and mini-health technology assessment: A funding decision-support tool for medical devices in a university hospital setting.

Martelli N, Hansen P, van den Brink H, Boudard A, Cordonnier AL, Devaux C, Pineau J, Prognon P, Borget I.

J Biomed Inform. 2016 Feb;59:201-8. doi: 10.1016/j.jbi.2015.12.002. Epub 2015 Dec 15.

11.

A Systematic Review of the Level of Evidence in Economic Evaluations of Medical Devices: The Example of Vertebroplasty and Kyphoplasty.

Martelli N, Devaux C, van den Brink H, Pineau J, Prognon P, Borget I.

PLoS One. 2015 Dec 10;10(12):e0144892. doi: 10.1371/journal.pone.0144892. eCollection 2015. Review.

12.

INTRODUCTION OF INNOVATIVE MEDICAL DEVICES AT FRENCH UNIVERSITY HOSPITALS: AN OVERVIEW OF HOSPITAL-BASED HEALTH TECHNOLOGY ASSESSMENT INITIATIVES.

Martelli N, Billaux M, Borget I, Pineau J, Prognon P, van den Brink H.

Int J Technol Assess Health Care. 2015 Jan;31(1-2):12-8. doi: 10.1017/S0266462315000057. Epub 2015 May 20.

PMID:
25991072
13.

Transcranial direct current stimulation as a treatment for auditory hallucinations.

Koops S, van den Brink H, Sommer IE.

Front Psychol. 2015 Mar 6;6:244. doi: 10.3389/fpsyg.2015.00244. eCollection 2015. Review.

14.

Special funding schemes for innovative medical devices in French hospitals: the pros and cons of two different approaches.

Martelli N, van den Brink H.

Health Policy. 2014 Jul;117(1):1-5. doi: 10.1016/j.healthpol.2014.04.007. Epub 2014 Apr 21.

15.

Estrous cycle-dependent morphology in the reproductive organs of the female Göttingen minipig.

de Rijk E, van den Brink H, Lensen J, Lambregts A, Lorentsen H, Peter B.

Toxicol Pathol. 2014 Dec;42(8):1197-211. doi: 10.1177/0192623314526136. Epub 2014 Mar 26.

PMID:
24670815
16.

[Hospital-based health technology assessment in France: how to proceed to evaluate innovative medical devices?].

Martelli N, van den Brink H, Denies F, Dervaux B, Germe AF, Prognon P, Pineau J.

Ann Pharm Fr. 2014 Jan;72(1):3-14. doi: 10.1016/j.pharma.2013.09.002. Epub 2013 Oct 14. Review. French.

PMID:
24438663
17.

Automated objective routine examination of optical quality of rigid endoscopes in a clinical setting.

Wientjes R, Noordmans HJ, van der Eijk JA, van den Brink H.

PLoS One. 2013;8(3):e59579. doi: 10.1371/journal.pone.0059579. Epub 2013 Mar 28.

18.

Who cares for former child soldiers? Mental health systems of care in sierra leone.

J Song S, van den Brink H, de Jong J.

Community Ment Health J. 2013 Oct;49(5):615-24. doi: 10.1007/s10597-013-9597-3. Epub 2013 Jan 22.

PMID:
23338835
19.

The development and implementation of pharmaceutical care across borders.

van den Brink H, Nanthini Haridass I, Siranyan V.

Ann Pharm Fr. 2012 Mar;70(2):82-7. doi: 10.1016/j.pharma.2011.12.002. Epub 2012 Jan 30. Review.

PMID:
22500959
20.

College Education and Social Trust: An Evidence-Based Study on the Causal Mechanisms.

Huang J, van den Brink HM, Groot W.

Soc Indic Res. 2011 Nov;104(2):287-310. Epub 2010 Oct 28.

21.

Assessment of parenting and developmental problems in toddlers: development and feasibility of a structured interview.

Staal II, van den Brink HA, Hermanns JM, Schrijvers AJ, van Stel HF.

Child Care Health Dev. 2011 Jul;37(4):503-11. doi: 10.1111/j.1365-2214.2011.01228.x. Epub 2011 Mar 24.

PMID:
21434969
22.

[Protocol for complementary and alternative medicine within the Dutch mental health services].

Hoenders HJ, Appelo MT, van den Brink H, Hartogs BM, Berger CJ.

Tijdschr Psychiatr. 2010;52(5):343-8. Dutch.

23.

The value of health.

Groot W, van den Brink HM.

BMC Health Serv Res. 2008 Jun 25;8:136. doi: 10.1186/1472-6963-8-136.

24.

The health effects of education: a meta-analysis.

Furnée CA, Groot W, van den Brink HM.

Eur J Public Health. 2008 Aug;18(4):417-21. doi: 10.1093/eurpub/ckn028. Epub 2008 Apr 23.

PMID:
18434381
25.

Intra-household work time synchronization: Togetherness or material benefits?

van Klaveren C, van den Brink HM.

Soc Indic Res. 2007 Oct;84(1):39-52. Epub 2007 Jan 18.

26.
27.

Ethnic differences in lifestyle and overweight in the Netherlands.

Cornelisse-Vermaat JR, van den Brink HM.

Obesity (Silver Spring). 2007 Feb;15(2):483-93.

28.

Increased production of chymosin by glycosylation.

van den Brink HJ, Petersen SG, Rahbek-Nielsen H, Hellmuth K, Harboe M.

J Biotechnol. 2006 Sep 1;125(2):304-10. Epub 2006 Apr 18.

PMID:
16621086
29.

The compensating income variation of cardiovascular disease.

Groot W, van den Brink HM.

Health Econ. 2006 Oct;15(10):1143-8.

PMID:
16615037
30.

Characterization of recombinant camel chymosin reveals superior properties for the coagulation of bovine and camel milk.

Kappeler SR, van den Brink HJ, Rahbek-Nielsen H, Farah Z, Puhan Z, Hansen EB, Johansen E.

Biochem Biophys Res Commun. 2006 Apr 7;342(2):647-54. Epub 2006 Feb 13.

PMID:
16488399
31.

Uncertainties in extreme surge level estimates from observational records.

van den Brink HW, Können GP, Opsteegh JD.

Philos Trans A Math Phys Eng Sci. 2005 Jun 15;363(1831):1377-86.

PMID:
16191655
32.

Money for health: the equivalent variation of cardiovascular diseases.

Groot W, Van Den Brink HM, Plug E.

Health Econ. 2004 Sep;13(9):859-72.

PMID:
15362178
33.
34.

[Short-term steroid therapy, sometimes with long-term sequelae].

van Schaardenburg D, van den Brink HR, Wieringa HJ.

Ned Tijdschr Geneeskd. 2001 Sep 15;145(37):1769-73. Review. Dutch.

PMID:
11582637
35.

Production of 3-nitrocatechol by oxygenase-containing bacteria: optimization of the nitrobenzene biotransformation by Nocardia S3.

Kieboom J, van den Brink H, Frankena J, de Bont JA.

Appl Microbiol Biotechnol. 2001 Apr;55(3):290-5.

PMID:
11341308
36.

Systemic lupus erythematosus. Disease outcome in patients with a disease duration of at least 10 years: second evaluation.

Swaak AJ, van den Brink HG, Smeenk RJ, Manger K, Kalden JR, Tosi S, Domljan Z, Rozman B, Logar D, Pokorny G, Kovacs L, Kovacs A, Vlachoyiannopoulos PG, Moutsopoulos HM, Chwalinska-Sadowska H, Kiss E, Cikes N, Anic B, Schneider M, Fischer R, Bombardieri S, Mosca M, Graninger W, Smolen JS.

Lupus. 2001;10(1):51-8.

PMID:
11243510
37.

Systemic lupus erythematosus: clinical features in patients with a disease duration of over 10 years, first evaluation.

Swaak AJ, van den Brink HG, Smeenk RJ, Manger K, Kalden JR, Tosi S, Marchesoni A, Domljan Z, Rozman B, Logar D, Pokorny G, Kovacs L, Kovacs A, Vlachoyiannopoulos PG, Moutsopoulos HM, Chwalinska-Sadowska H, Dratwianka B, Kiss E, Cikes N, Branimir A, Schneider M, Fischer R, Bombardieri S, Mosca M, Smolen JS, et al.

Rheumatology (Oxford). 1999 Oct;38(10):953-8.

PMID:
10534545
38.

Cytochrome P450 enzyme systems in fungi.

van den Brink HM, van Gorcom RF, van den Hondel CA, Punt PJ.

Fungal Genet Biol. 1998 Feb;23(1):1-17. Review.

PMID:
9501474
39.

Cytokine production in whole blood cell cultures of patients with rheumatoid arthritis.

Swaak AJ, van den Brink HG, Aarden LA.

Ann Rheum Dis. 1997 Nov;56(11):693-5.

40.

Randomised comparison of combined step-down prednisolone, methotrexate and sulphasalazine with sulphasalazine alone in early rheumatoid arthritis.

Boers M, Verhoeven AC, Markusse HM, van de Laar MA, Westhovens R, van Denderen JC, van Zeben D, Dijkmans BA, Peeters AJ, Jacobs P, van den Brink HR, Schouten HJ, van der Heijde DM, Boonen A, van der Linden S.

Lancet. 1997 Aug 2;350(9074):309-18. Erratum in: Lancet 1998 Jan 17;351(9097):220.

PMID:
9251634
41.
42.

Common variable immunodeficiency in a patient with systemic lupus erythematosus.

Swaak AJ, van den Brink HG.

Lupus. 1996 Jun;5(3):242-6. Review.

PMID:
8803898
43.

Randomised placebo-controlled study of stopping second-line drugs in rheumatoid arthritis.

ten Wolde S, Breedveld FC, Hermans J, Vandenbroucke JP, van de Laar MA, Markusse HM, Janssen M, van den Brink HR, Dijkmans BA.

Lancet. 1996 Feb 10;347(8998):347-52.

PMID:
8598699
44.

Cytokine production (IL-6 and TNF alpha) in whole blood cell cultures of patients with systemic lupus erythematosus.

Swaak AJ, van den Brink HG, Aarden LA.

Scand J Rheumatol. 1996;25(4):233-8.

PMID:
8792800
45.

Cloning and characterization of the NADPH cytochrome P450 oxidoreductase gene from the filamentous fungus Aspergillus niger.

van den Brink HJ, van Zeijl CM, Brons JF, van den Hondel CA, van Gorcom RF.

DNA Cell Biol. 1995 Aug;14(8):719-29.

PMID:
7646819
46.

Negative pion photoproduction from 15N in the region of the Delta resonance.

Shaw J, Choi H, Kobayashi T, Stoler P, Gresko T, Keeter K, Mitchell JH, Norum B, Welch TP, Chung HT, Kim JC, van den Brink HB, Hesselink WH, Bergstrom JC, Hallin EL, Kaplan HS, Skopik DM, Vogt JM.

Phys Rev C Nucl Phys. 1995 Jul;52(1):199-202. No abstract available.

PMID:
9970499
47.

Neutral-pion electroproduction on the proton near threshold.

van den Brink HB, Blok HP, Bobeldijk I I, Bouwhuis M, Dodge GE, Harakeh MN, Hesselink WH, Ireland DG, de Jager CW, Jans E, de Jonge N, Kalantar-Nayestanaki N, Kasdorp WJ, Ketel TJ, Konijn J, Lapikás L, van Leeuwe JJ, van der Meer RL, Nooren GJ, Norum BE, Passchier E, Pellegrino AR, Spaltro CM, van der Steenhoven G, Steijger JJ, Templon JA, Theunissen JA, van Uden MA, de Vries H, de Vries R, de Witt Huberts PK.

Phys Rev Lett. 1995 May 1;74(18):3561-3564. No abstract available.

PMID:
10058236
48.
49.

High-momentum protons in 208Pb.

Bobeldijk I I, Bouwhuis M, Ireland DG, de Jager CW, Jans E, de Jonge N, Kasdorp WJ, Konijn J, Lapikás L, van Leeuwe JJ, van der Meer RL, Nooren GJ, Passchier E, Schroevers M, van der Steenhoven G, Steijger JJ, Theunissen JA, van Uden MA, de Vries H, de Vries R, de Witt Huberts PK, Blok HP, van den Brink HB, Dodge GE, Harakeh MN, Hesselink WH, Kalantar-Nayestanaki N, Pellegrino A, Spaltro CM, Templon JA, Hicks RS, Kelly JJ, Marchand C.

Phys Rev Lett. 1994 Nov 14;73(20):2684-2687. No abstract available.

PMID:
10057166
50.

Supplemental Content

Loading ...
Support Center